发明名称 Methods of monitoring for adherence to aripiprazole therapy
摘要 Methods for helping to monitor subject adherence with a prescribed antipsychotic drug treatment regimen are disclosed.
申请公布号 US9170264(B2) 申请公布日期 2015.10.27
申请号 US201414213392 申请日期 2014.03.14
申请人 Ameritox, Ltd. 发明人 McIntire Gregory L.;Morris Ayodele
分类号 G01N33/70;G01N30/72;G01N33/68 主分类号 G01N33/70
代理机构 Perkins Coie LLP 代理人 Perkins Coie LLP
主权项 1. A method for recommending a modification to an aripiprazole therapy, the method comprising: identifying a subject who is prescribed aripiprazole therapy; determining a prescribed aripiprazole dose associated with the prescribed aripiprazole therapy; measuring a concentration of OPC3373 and a creatinine level in urine of the subject; normalizing the concentration of OPC3373 as a function of the creatinine level; identifying the subject as non-adherent to aripiprazole therapy if the normalized concentration of OPC3373 is less than a predetermined level, and as adherent to aripirazole therapy if the normalized concentration of OPC3373 is greater than the predetermined level; and recommending a modification to the prescribed aripiprazole dose if the subject is identified as non-adherent, wherein the modification comprises a discontinuation of the aripiprazole therapy or a replacement of the aripiprazole therapy with a new therapeutic regimen.
地址 Baltimore MD US